» Articles » PMID: 33820887

Bioactive Levan-Type Exopolysaccharide Produced by ZMR7: Characterization and Optimization for Enhanced Production

Overview
Date 2021 Apr 6
PMID 33820887
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Levan is an industrially important, functional biopolymer with considerable applications in the food and pharmaceutical fields owing to its safety and biocompatibility. Here, levan-type exopolysaccharide produced by Pantoea agglomerans ZMR7 was purified by cold ethanol precipitation and characterized using TLC, FTIR, H, and C NMR spectroscopy. The maximum production of levan (28.4 g/l) was achieved when sucrose and ammonium chloride were used as carbon and nitrogen sources, respectively, at 35°C and an initial pH of 8.0. Some biomedical applications of levan like antitumor, antiparasitic, and antioxidant activities were investigated in vitro. The results revealed the ability of levan at different concentrations to decrease the viability of rhabdomyosarcoma and breast cancer cells compared with untreated cancer cells. Levan appeared also to have high antiparasitic activity against the promastigote of . Furthermore, levan had strong DPPH radical scavenging (antioxidant) activity. These findings suggest that levan produced by ZMR7 can serve as a natural biopolymer candidate for the pharmaceutical and medical fields.

Citing Articles

Advances in Microbial Exopolysaccharides: Present and Future Applications.

Nguyen H, Pham T, Nguyen P, Le-Buanec H, Rabetafika H, Razafindralambo H Biomolecules. 2024; 14(9).

PMID: 39334928 PMC: 11430787. DOI: 10.3390/biom14091162.


Interaction and effects of temperature preference under a controlled environment on the diversity and abundance of the microbiome in (Diptera: Psychodidae).

Duque-Granda D, Vivero-Gomez R, Junca H, Cadavid-Restrepo G, Moreno-Herrera C Biotechnol Rep (Amst). 2024; 44:e00857.

PMID: 39328926 PMC: 11424975. DOI: 10.1016/j.btre.2024.e00857.


A Rare Organism Causing Cholecystitis With Bacteremia in a Breast Cancer Patient.

Ghaly M, Zakala A, Penmethsa K, Johnson-Pich K Cureus. 2024; 16(2):e54549.

PMID: 38516448 PMC: 10955448. DOI: 10.7759/cureus.54549.


Coculture of bacterial levans and evaluation of its anti-cancer activity against hepatocellular carcinoma cell lines.

Wahab W, Shafey H, Mahrous K, Esawy M, Saleh S Sci Rep. 2024; 14(1):3173.

PMID: 38326332 PMC: 10850072. DOI: 10.1038/s41598-024-52699-9.


Elaboration of Nanostructured Levan-Based Colloid System as a Biological Alternative with Antimicrobial Activity for Applications in the Management of Pathogenic Microorganisms.

Radenkovs V, Valdovska A, Galina D, Cairns S, Jakovlevs D, Gaidukovs S Nanomaterials (Basel). 2023; 13(22).

PMID: 37999323 PMC: 10674346. DOI: 10.3390/nano13222969.


References
1.
Sarilmiser H, Ates O, Ozdemir G, Arga K, Toksoy Oner E . Effective stimulating factors for microbial levan production by Halomonas smyrnensis AAD6T. J Biosci Bioeng. 2014; 119(4):455-63. DOI: 10.1016/j.jbiosc.2014.09.019. View

2.
Dahech I, Belghith K, Belghith H, Mejdoub H . Partial purification of a Bacillus licheniformis levansucrase producing levan with antitumor activity. Int J Biol Macromol. 2012; 51(3):329-35. DOI: 10.1016/j.ijbiomac.2012.04.030. View

3.
Bouallegue A, Casillo A, Chaari F, La Gatta A, Lanzetta R, Corsaro M . Levan from a new isolated Bacillus subtilis AF17: Purification, structural analysis and antioxidant activities. Int J Biol Macromol. 2019; 144:316-324. DOI: 10.1016/j.ijbiomac.2019.12.108. View

4.
Taylan O, Yilmaz M, Dertli E . Partial characterization of a levan type exopolysaccharide (EPS) produced by Leuconostoc mesenteroides showing immunostimulatory and antioxidant activities. Int J Biol Macromol. 2019; 136:436-444. DOI: 10.1016/j.ijbiomac.2019.06.078. View

5.
Belghith K, Dahech I, Belghith H, Mejdoub H . Microbial production of levansucrase for synthesis of fructooligosaccharides and levan. Int J Biol Macromol. 2012; 50(2):451-8. DOI: 10.1016/j.ijbiomac.2011.12.033. View